Local Epidermal Endocrine Estrogen Protects Human Melanocytes against Oxidative Stress, a Novel Insight into Vitiligo Pathology

• DOI: 10.3390/ijms22010269
• Publication Date: 2020-12-30T00:55:25Z
• Authors: Asako Yamamoto; Lingli Yang; Yasutaka Kuroda; Jiao Guo; Lanting Teng; Daisuke Tsuruta; Ichiro Katayama
• Keywords: vitiligo; Keratinocytes; melanocyte; Vitiligo; Gene Expression; keratinocyte; Cell Count; Article; Receptors, G-Protein-Coupled; Estradiol Dehydrogenases; 03 medical and health sciences; estrogen; oxidative stress; Humans; Melanins; 0303 health sciences; Cell Death; Estrogens; 3. Good health; Oxidative Stress; Epidermal Cells; Receptors, Estrogen; Melanocytes; Disease Susceptibility; Epidermis

As the outermost barrier of the body, skin is a major target of oxidative stress. In the brain, estrogen has been reported synthesized locally and protects neurons from oxidative stress. Here, we explored whether estrogen is also locally synthesized in the skin to protect from oxidative stress and whether aberrant local estrogen synthesis is involved in skin disorders. Enzymes and estrogen receptor expression in skin cells were examined first by quantitative real-time PCR and Western blot analyses. Interestingly, the estrogen synthesis enzyme was mainly localized in epidermal keratinocytes and estrogen receptors were mainly expressed in melanocytes among 13 kinds of cultured human skin cells. The most abundant estrogen synthesis enzyme expressed in the epidermis was 17β-hydroxysteroid dehydrogenase 1 (HSD17β1) localized in keratinocytes, and the most dominant estrogen receptor expressed in the epidermis was G protein-coupled estrogen receptor 1 (GPER1) in melanocytes. To investigate whether keratinocyte-derived estradiol could protect melanocytes from oxidative stress, cultured human primary epidermal melanocytes (HEMn-MPs) were treated with H2O2 in the presence or absence of 17β estradiol or co-cultured with HSD17β1 siRNA-transfected keratinocytes. Keratinocyte-derived estradiol exhibited protective effects against H2O2-induced cell death. Further, reduced expression of HSD17β1 in the epidermis of skin from vitiligo patients was observed compared to the skin from healthy donors or in the normal portions of the skin in vitiligo patients. Our results suggest a possible new target for interventions that may be used in combination with current therapies for patients with vitiligo.